Virtual clinical trial collaboration with Science 37

Boehringer Ingelheim Initiates a Collaborative Partnership with Science 37 to Accelerate Patient Centricity in the Development of Novel Therapies  Boehringer Ingelheim collaborates with Science 37 to accelerate the clinical development of new therapies worldwide  Science 37 ’s technology enables patients to remotely participate in clinical studies, which enables increased patient diversity, study efficiency and speed, while decreasing patient burden
Source: Boehringer Ingelheim Corporate News - Category: Research Source Type: news